Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/32900
Title: | A new measure of treatment effect in clinical trials involving competing risks based on generalized pairwise comparisons | Authors: | Cantagallo, Eva De Backer, Mickael KICINSKI, Michal Ozenne, Brice Collette, Laurence LEGRAND, Catherine BUYSE, Marc Peron, Julien |
Issue Date: | 2021 | Publisher: | WILEY | Source: | Biometrical journal (1977), 63 (2), p. 272-288 | Abstract: | In survival analysis with competing risks, the treatment effect is typically expressed using cause-specific or subdistribution hazard ratios, both relying on proportional hazards assumptions. This paper proposes a nonparametric approach to analyze competing risks data based on generalized pairwise comparisons (GPC). GPC estimate the net benefit, defined as the probability that a patient from the treatment group has a better outcome than a patient from the control group minus the probability of the opposite situation, by comparing all pairs of patients taking one patient from each group. GPC allow using clinically relevant thresholds and simultaneously analyzing multiple prioritized endpoints. We show that under proportional subdistribution hazards, the net benefit for competing risks settings can be expressed as a decreasing function of the subdistribution hazard ratio, taking a value 0 when the latter equals 1. We propose four net benefit estimators dealing differently with censoring. Among them, the Peron estimator uses the Aalen-Johansen estimator of the cumulative incidence functions to classify the pairs for which the patient with the best outcome could not be determined due to censoring. We use simulations to study the bias of these estimators and the size and power of the tests based on the net benefit. The Peron estimator was approximately unbiased when the sample size was large and the censoring distribution's support sufficiently wide. With one endpoint, our approach showed a comparable power to a proportional subdistribution hazards model even under proportional subdistribution hazards. An application of the methodology in oncology is provided. | Notes: | Cantagallo, E (corresponding author), European Org Res & Treatment Canc EORTC, Stat Dept, Ave Emmanuel Mounier 83-11, B-1200 Brussels, Belgium. eva.cantagallo@eortc.org |
Other: | Cantagallo, E (corresponding author), European Org Res & Treatment Canc EORTC, Stat Dept, Ave Emmanuel Mounier 83-11, B-1200 Brussels, Belgium. eva.cantagallo@eortc.org | Keywords: | clinical trial;competing risks;generalized pairwise comparisons;multicriteria analysis;survival analysis | Document URI: | http://hdl.handle.net/1942/32900 | ISSN: | 0323-3847 | e-ISSN: | 1521-4036 | DOI: | 10.1002/bimj.201900354 | ISI #: | 000569715000001 | Rights: | 2020Wiley-VCHGmbH | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2022 |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Biometrical J - 2020 - Cantagallo - A new measure of treatment effect in clinical trials involving competing risks based on.pdf Restricted Access | Published version | 1.05 MB | Adobe PDF | View/Open Request a copy |
WEB OF SCIENCETM
Citations
5
checked on Sep 21, 2024
Page view(s)
36
checked on Sep 6, 2022
Download(s)
6
checked on Sep 6, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.